Exact Mass: 461.187
Exact Mass Matches: 461.187
Found 500 metabolites which its exact mass value is equals to given mass value 461.187
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Morphine-3-glucuronide
Morphine-3-glucuronide belongs to the family of Morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic. D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants
Morphine-6-glucuronide
Morphine-6-glucuronide (M6G) is a major active metabolite of morphine, and as such is the molecule responsible for much of the pain-relieving effects of morphine (and thus heroin). M6G is formed from morphine by the enzyme UDP-Glucuronosyltransferase-2B7 (UGT2B7). M6G can accumulate to toxic levels in kidney failure. D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate
Orphenadrine citrate
M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents > M03BC - Ethers, chemically close to antihistamines D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Orphenadrine citrate is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine citrate relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine citrate is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases[1][2].
Hydromorphone-3-glucuronide
Hydromorphone-3-glucuronide is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)
Hydromorphone 3-beta-O-glucuronide
Hydromorphone 3-beta-O-glucuronide is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)
3-cis-Hydroxyglipizide
3-cis-Hydroxyglipizide is a metabolite of glipizide. Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas. Mechanism of action is produced by blocking potassium channels in the beta cells of the islets of Langerhans. (Wikipedia)
4-trans-Hydroxyglipizide
4-trans-Hydroxyglipizide is a metabolite of glipizide. Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas. Mechanism of action is produced by blocking potassium channels in the beta cells of the islets of Langerhans. (Wikipedia)
Biotin pantothenate
Embusartan
Gln Ala Glu Asp
Glu Ala Lys Asp
Ser Val Gln Glu
Lys Ala Glu Asp
Ala Glu Lys Asp
Thr Asn Ile Asp
Thr Gln Val Asp
Ser Gln Ile Asp
Lys Asp Ala Glu
Ala Ala Asp Trp
Ala Ala Trp Asp
Ala Asp Ala Trp
Ala Asp Glu Lys
Ala Asp Glu Gln
Ala Asp Lys Glu
Ala Asp Gln Glu
Ala Asp Trp Ala
Ala Glu Asp Lys
Ala Glu Asp Gln
Ala Glu Glu Asn
Ala Glu Gly Trp
Ala Glu Asn Glu
Ala Glu Gln Asp
Ala Glu Trp Gly
Ala Gly Glu Trp
Ala Gly Trp Glu
Ala Lys Asp Glu
Ala Lys Glu Asp
Ala Asn Glu Glu
Ala Gln Asp Glu
Ala Gln Glu Asp
Ala Trp Ala Asp
Ala Trp Asp Ala
Ala Trp Glu Gly
Ala Trp Gly Glu
Cys Asp Lys Pro
Cys Asp Pro Lys
Cys Gly Pro Trp
Cys Gly Trp Pro
Cys Lys Asp Pro
Cys Lys Pro Asp
Cys Pro Asp Lys
Cys Pro Gly Trp
Cys Pro Lys Asp
Cys Pro Arg Ser
Cys Pro Ser Arg
Cys Pro Trp Gly
Cys Arg Pro Ser
Cys Arg Ser Pro
Cys Ser Pro Arg
Cys Ser Arg Pro
Cys Trp Gly Pro
Cys Trp Pro Gly
Asp Ala Ala Trp
Asp Ala Glu Lys
Asp Ala Glu Gln
Asp Ala Lys Glu
Asp Ala Gln Glu
Asp Ala Trp Ala
Asp Cys Lys Pro
Asp Cys Pro Lys
Asp Asp Gly Arg
Asp Asp Asn Val
Asp Asp Arg Gly
Asp Asp Val Asn
Asp Glu Ala Lys
Asp Glu Ala Gln
Asp Glu Lys Ala
Asp Glu Gln Ala
Asp Gly Asp Arg
Asp Gly Arg Asp
Asp Ile Asn Thr
Asp Ile Gln Ser
Asp Ile Ser Gln
Asp Ile Thr Asn
Asp Lys Ala Glu
Asp Lys Cys Pro
Asp Lys Glu Ala
Asp Lys Pro Cys
Asp Leu Asn Thr
Asp Leu Gln Ser
Asp Leu Ser Gln
Asp Leu Thr Asn
Asp Asn Asp Val
Asp Asn Ile Thr
Asp Asn Leu Thr
Asp Asn Thr Ile
Asp Asn Thr Leu
Asp Asn Val Asp
Asp Pro Cys Lys
Asp Pro Lys Cys
Asp Gln Ala Glu
Asp Gln Glu Ala
Asp Gln Ile Ser
Asp Gln Leu Ser
Asp Gln Ser Ile
Asp Gln Ser Leu
Asp Gln Thr Val
Asp Gln Val Thr
Asp Arg Asp Gly
Asp Arg Gly Asp
Asp Ser Ile Gln
Asp Ser Leu Gln
Asp Ser Gln Ile
Asp Ser Gln Leu
Asp Thr Ile Asn
Asp Thr Leu Asn
Asp Thr Asn Ile
Asp Thr Asn Leu
Asp Thr Gln Val
Asp Val Asp Asn
Asp Val Asn Asp
Asp Trp Ala Ala
Glu Ala Asp Gln
Glu Ala Glu Asn
Glu Ala Gly Trp
Glu Ala Asn Glu
Glu Ala Gln Asp
Glu Ala Trp Gly
Glu Asp Ala Gln
Glu Asp Gln Ala
Glu Glu Ala Asn
Glu Glu Gly Gln
Glu Glu Asn Ala
Glu Glu Gln Gly
Glu Gly Ala Trp
Glu Gly Glu Gln
Glu Gly Gln Glu
Glu Gly Trp Ala
Glu Asn Ala Glu
Glu Asn Glu Ala
Glu Gln Ala Asp
Glu Gln Asp Ala
Glu Gln Glu Gly
Glu Gln Gly Glu
Glu Trp Ala Gly
Glu Trp Gly Ala
Gly Ala Glu Trp
Gly Ala Trp Glu
Gly Cys Pro Trp
Gly Cys Trp Pro
Gly Asp Asp Arg
Gly Asp Arg Asp
Gly Glu Ala Trp
Gly Glu Glu Gln
Gly Glu Gln Glu
Gly Glu Trp Ala
Gly Pro Cys Trp
Gly Pro Trp Cys
Gly Gln Glu Glu
Gly Arg Asp Asp
Gly Trp Ala Glu
Gly Trp Cys Pro
Gly Trp Glu Ala
Gly Trp Pro Cys
Lys Cys Asp Pro
Lys Cys Pro Asp
Lys Asp Cys Pro
Lys Asp Pro Cys
Lys Pro Cys Asp
Lys Pro Asp Cys
Met Asn Pro Thr
Met Asn Thr Pro
Met Pro Asn Thr
Met Pro Gln Ser
Met Pro Ser Gln
Met Pro Thr Asn
Met Gln Pro Ser
Met Gln Ser Pro
Met Ser Pro Gln
Met Ser Gln Pro
Met Thr Asn Pro
Met Thr Pro Asn
Asn Ala Glu Glu
Asn Asp Asp Val
Asn Asp Val Asp
Asn Glu Ala Glu
Asn Glu Glu Ala
Asn Met Pro Thr
Asn Met Thr Pro
Asn Asn Asn Thr
Asn Asn Gln Ser
Asn Asn Ser Gln
Asn Asn Thr Asn
Asn Pro Met Thr
Asn Pro Thr Met
Asn Gln Asn Ser
Asn Gln Ser Asn
Asn Ser Asn Gln
Asn Ser Gln Asn
Asn Thr Met Pro
Asn Thr Asn Asn
Asn Thr Pro Met
Asn Val Asp Asp
Pro Cys Asp Lys
Pro Cys Gly Trp
Pro Cys Lys Asp
Pro Cys Arg Ser
Pro Cys Ser Arg
Pro Cys Trp Gly
Pro Asp Cys Lys
Pro Asp Lys Cys
Pro Gly Cys Trp
Pro Gly Trp Cys
Pro Lys Cys Asp
Pro Lys Asp Cys
Pro Met Asn Thr
Pro Met Gln Ser
Pro Met Ser Gln
Pro Met Thr Asn
Pro Asn Met Thr
Pro Asn Thr Met
Pro Gln Met Ser
Pro Gln Ser Met
Pro Arg Cys Ser
Pro Arg Ser Cys
Pro Ser Cys Arg
Pro Ser Met Gln
Pro Ser Gln Met
Pro Ser Arg Cys
Pro Thr Met Asn
Pro Thr Asn Met
Pro Trp Cys Gly
Pro Trp Gly Cys
Gln Ala Asp Glu
Gln Asp Ala Glu
Gln Asp Glu Ala
Gln Glu Ala Asp
Gln Glu Asp Ala
Gln Glu Glu Gly
Gln Glu Gly Glu
Gln Gly Glu Glu
Gln Met Pro Ser
Gln Met Ser Pro
Gln Asn Asn Ser
Gln Asn Ser Asn
Gln Pro Met Ser
Gln Pro Ser Met
Gln Ser Leu Asp
Gln Ser Met Pro
Gln Ser Asn Asn
Gln Ser Pro Met
Gln Ser Val Glu
Gln Thr Asp Val
Gln Thr Val Asp
Gln Val Asp Thr
Gln Val Glu Ser
Gln Val Ser Glu
Gln Val Thr Asp
Arg Cys Pro Ser
Arg Cys Ser Pro
Arg Asp Asp Gly
Arg Asp Gly Asp
Arg Gly Asp Asp
Arg Pro Cys Ser
Arg Pro Ser Cys
Arg Ser Cys Pro
Arg Ser Pro Cys
Ser Cys Pro Arg
Ser Cys Arg Pro
Ser Asp Ile Gln
Ser Asp Leu Gln
Ser Asp Gln Ile
Ser Asp Gln Leu
Ser Glu Ile Asn
Ser Glu Leu Asn
Ser Glu Asn Ile
Ser Glu Asn Leu
Ser Glu Gln Val
Ser Glu Val Gln
Ser Ile Asp Gln
Ser Ile Glu Asn
Ser Ile Asn Glu
Ser Ile Gln Asp
Ser Leu Asp Gln
Ser Leu Glu Asn
Ser Leu Asn Glu
Ser Leu Gln Asp
Ser Met Pro Gln
Ser Met Gln Pro
Ser Asn Glu Ile
Ser Asn Glu Leu
Ser Asn Ile Glu
Ser Asn Leu Glu
Ser Asn Asn Gln
Ser Asn Gln Asn
Ser Pro Cys Arg
Ser Pro Met Gln
Ser Pro Gln Met
Ser Pro Arg Cys
Ser Gln Asp Ile
Ser Gln Asp Leu
Ser Gln Glu Val
Ser Gln Leu Asp
Ser Gln Met Pro
Ser Gln Asn Asn
Ser Gln Pro Met
Ser Gln Val Glu
Ser Arg Cys Pro
Ser Arg Pro Cys
Ser Val Glu Gln
Thr Asp Ile Asn
Thr Asp Leu Asn
Thr Asp Asn Ile
Thr Asp Asn Leu
Thr Asp Gln Val
Thr Asp Val Gln
Thr Glu Asn Val
Thr Glu Val Asn
Thr Ile Asp Asn
Thr Ile Asn Asp
Thr Leu Asp Asn
Thr Leu Asn Asp
Thr Met Asn Pro
Thr Met Pro Asn
Thr Asn Asp Ile
Thr Asn Asp Leu
Thr Asn Glu Val
Thr Asn Leu Asp
Thr Asn Met Pro
Thr Asn Asn Asn
Thr Asn Pro Met
Thr Asn Val Glu
Thr Pro Met Asn
Thr Pro Asn Met
Thr Gln Asp Val
Thr Val Asp Gln
Thr Val Glu Asn
Thr Val Asn Glu
Thr Val Gln Asp
Val Asp Asp Asn
Val Asp Asn Asp
Val Asp Gln Thr
Val Asp Thr Gln
Val Glu Asn Thr
Val Glu Gln Ser
Val Glu Ser Gln
Val Glu Thr Asn
Val Asn Asp Asp
Val Asn Glu Thr
Val Asn Thr Glu
Val Gln Asp Thr
Val Gln Glu Ser
Val Gln Ser Glu
Val Gln Thr Asp
Val Ser Glu Gln
Val Ser Gln Glu
Val Thr Asp Gln
Val Thr Glu Asn
Val Thr Asn Glu
Val Thr Gln Asp
Trp Ala Ala Asp
Trp Ala Asp Ala
Trp Ala Glu Gly
Trp Ala Gly Glu
Trp Cys Gly Pro
Trp Cys Pro Gly
Trp Asp Ala Ala
Trp Glu Ala Gly
Trp Glu Gly Ala
Trp Gly Ala Glu
Trp Gly Cys Pro
Trp Gly Glu Ala
Trp Gly Pro Cys
Trp Pro Cys Gly
Trp Pro Gly Cys
3-[2-[[4-(diethylamino)phenyl]diazenyl]-6-ethoxy-1,3-benzothiazol-3-ium-3-yl]propanamide,chloride
Ethyl 6-[4-(Diphenylamino)phenyl]coumarin-3-carboxylate
Embusartan
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist
5-[(Z)-(3-carboxy-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)-[4-(diethylamino)phenyl]methyl]-2-hydroxy-3-methylbenzoic acid
[2-[2-[2-[2-Formyl-5-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenoxy]ethoxy]ethoxy]ethyl]carbamic acid 1,1-dimethylethyl ester
Alogliptin benzoate
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Bms-754807
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(S)-2-(4-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-3-(3-hydroxyphenyl)-4-methyl-2H-chromen-6-ol
Pivcefalexin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
N-[(2S,6R)-2-[(L-Ala-D-gammaGlu-)Amino]-6-amino-6-carboxyhexanoyl]-D-Ala-OH
3-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]propanoyl 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentaneperoxoate
N-tert-butyl-3-(3-tert-butyl-1-methyl-7-oxo-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonamide
4-hydroxy-17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
2-[8-[[Bis(phenylmethyl)amino]methyl]-3-methyl-2,6-dioxo-7-purinyl]acetic acid ethyl ester
4-[1-[(4-methyl-2-oxo-1-benzopyran-7-yl)amino]-3-oxo-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester
Methyl 2-[3-[(7-chloro-4-quinolyl)amino]propylamino]-4-methyl-6-phenyl-pyrimidine-5-carboxylate
3-hydroxy-17-oxoestra-1,3,5(10)-trien-4-yl beta-D-glucopyranosiduronate
1,4:3,6-Dianhydro-2-[(benzylcarbamoyl)amino]-2,5-dideoxy-5-{[4-(4-methoxyphenyl)-2-pyrimidinyl]amino}-L-iditol
2-hydroxy-17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronate
18-(2,3-Dimethoxyphenyl)-15-phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12(17),13-heptaen-16-imine
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
(1S,9R,10R,11R)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1R)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-N-(2-methoxyethyl)-12-(2-methylphenyl)sulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
(1S,9R,10R,11R)-12-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1S)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1S)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
(1R,9S,10S,11S)-12-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-N-(2-methoxyethyl)-12-(2-methylphenyl)sulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridin-4-ylethyl)acetamide
(1R,9S,10S,11S)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1R)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(1R)-7-methoxy-1-(pyridin-4-ylmethyl)-2-(2-thiazolylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
[(1S)-7-methoxy-1-(pyridin-4-ylmethyl)-2-(2-thiazolylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
3-hydroxy-17-oxoestra-1,3,5(10)-trien-2-yl beta-D-glucopyranosiduronate
(E,5Z)-5-(chloromethylidene)-2-methyl-N-[3-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]butan-2-yl]dec-2-en-9-ynamide
Morphine-6-glucuronide
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist > C1657 - Opiate
m-3-g hydrate
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants